HAP Trading’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,600
Closed -$202K 1613
2022
Q3
$202K Sell
12,600
-85,000
-87% -$1.32M 0.01% 617
2022
Q2
$1.66M Buy
97,600
+2,700
+3% +$36.2K 0.08% 199
2022
Q1
$1.24M Buy
94,900
+51,000
+116% +$948K 0.05% 300
2021
Q4
$593K Sell
43,900
-7,700
-15% -$265K 0.02% 624
2021
Q3
$504K Buy
51,600
+13,500
+35% +$740K 0.02% 677
2021
Q2
$195K Sell
38,100
-100
-0.3% -$3.69K 0.01% 1023
2021
Q1
$340K Buy
38,200
+7,600
+25% +$433K 0.02% 604
2020
Q4
$131K Buy
30,600
+15,300
+100% +$629K ﹤0.01% 1084
2020
Q3
$51K Sell
15,300
-400
-3% -$13K ﹤0.01% 963
2020
Q2
$50K Buy
+15,700
New +$410K ﹤0.01% 1038
2020
Q1
Sell
-182,500
Closed -$51K 1281
2019
Q4
$51K Buy
182,500
+34,000
+23% +$849K ﹤0.01% 704
2019
Q3
$37K Sell
148,500
-200
-0.1% -$4.95K ﹤0.01% 794
2019
Q2
$69K Buy
148,700
+13,200
+10% +$315K 0.01% 670
2019
Q1
$93K Buy
+135,500
New +$3.07M 0.01% 558

Other funds holding EDIT

HAP Trading's EDIT Position: Q2 2022 in Review

HAP Trading sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 36,831 shares — an estimated $494K sold.

HAP Trading first reported a position in EDIT in Q1 2019 and held it in 9 quarters. The position peaked at $1.16M in Q3 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • HAP Trading reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 36,831 Editas Medicine shares in Q2 2022, an estimated $494K.
  • HAP Trading first reported a position in Editas Medicine in Q1 2019 and held it in 9 quarters.
  • HAP Trading's Editas Medicine position peaked at $1.16M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.